近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Shi W, Kou YM, Xiao JH, Zhang LJ, Gao F, Kong W, Su WH, Jiang CL*, Zhang Y*. Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants. Vaccine. 2018, In press.
2. Li F, Chen Y, Liu SB, Qi J, Wang WY, Wang CH, Zhong RY, Chen ZJ, Li XM, Guan YZ, Kong W, Zhang Y*. Size-controlled fabrication of zein nano/microparticles by modified anti-solvent precipitation with/without sodium caseinate. Int. J. Nanomedicine. 2017,12: 8197—8209.
3. Feng J, Chen Y, Li F, Cui LL, Shi NQ, Kong W, Zhang Y*. Synthesis, Characterization and In Vitro Evaluation of a Novel Glycol Chitosan-EDTA Conjugate to Inhibit Aminopeptidase-Mediated Degradation of Thymopoietin Oligopeptides. Molecules. 2017, 22(8): 1253.
4. Zhang Y*, Cui LL, Li F, Shi NQ, Li CL, Yu XH, Chen Y*, Kong W. Design, fabrication and biomedical applications of zein-based nano/micro-carrier systems. Int J Pharm. 2016,513(1-2):191-210.
5. Zhang Y*, Feng J, Cui LL, Zhang YB, Li WZ, Li CL, Shi NQ, Chen Y*, Kong W. Investigation into efficiency of a novel glycol chitosan-bestatin conjugate to protect thymopoietin oligopeptides from enzymatic degradation. J Pharm. Sci.(Ronald T. Borchardt Dedicated Issue) 2016,105(2): 828-837.
6. Sun YN, Wang MS, Sun BX, Li F, Liu SB, Zhang Y*, Zhou Y, Chen Y*, Kong W.An investigation into the gastrointestinal stability of exenatide in the presence of pure enzymes, everted intestinal rings and intestinal homogenates. Biol Pharm Bull. 2016,39(1):42-48.
7. Zhang Y*, Cui LL, Chen Y, Zhang H, Zhong J, Sun YN, Shi NQ, Li CL, Kong W*. Zein-based nanofibres for drug delivery: Classes and current applications. Curr Pharm Des. 2015,21(22)：3199-3207.
8. Zhang Y*, Cui LL, Che XX, Zhang H, Shi NQ, Li CL, Chen Y*, Kong W. Zein-based films and their usage for controlled delivery: Origin, classes and current landscape. J Control Release. 2015,206:206-217.
9. Shi NQ*, Qi XR*, Xiang B, Zhang Y. A survey on “Trojan Horse” peptides: Opportunities, issues and controlled entry to "Troy". J Control Release. 2014,194:53-70.
10. Wang MS, Zhang Y, Sun BX, Sun YN, Gong X, Wu YG, Zhang XZ, Kong W*, Chen Y*. Permeability of Exendin-4-Loaded Chitosan Nanoparticles across MDCK Cell Monolayers and Rat Small Intestine. Biol Pharm Bull. 2014,37(5):740-747.
11. Wang MS, Zhang Y, Feng J, Gu TJ, Dong QG, Yang X, Sun YN, Wu YG, Chen Y*, Kong W*. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4. Int. J. Nanomedicine. 2013,8:1141-54.
12. Dong QG, Zhang Y, Wang MS, Feng J, Zhang HH, Wu YG, Gu TJ, Yu XH, Jiang CL, Chen Y*, Li W, Kong W*. Improvement of enzymatic stability and intestinal permeability of deuterohemin-peptide conjugates by specific multi-site N-methylation. Amino Acids. 2012,43(6):2431-41.
13. Wang MS, Sun BX, Feng J, Zhang HH, Liu B, Li C, Chen Y*, Zhang Y*, Kong W. Investigation of transport mechanism of exendin-4 across MDCK cell monolayers. Biol. Pharm. Bull. 2012,35(5):745-52.
14. Zhang Y*, Deng YJ, Wang XL, Xu JH, Li ZQ*. Conformational and bioactivity analysis of insulin: freeze-drying TBA/water co-solvent system in the presence of surfactant and sugar. Int. J. Pharm. 2009,371(1-2):71-81.
15. Zhang Y, Deng YJ*, Lu M, Duncan Q.M. Craig, Li ZQ*. A spectroscopic investigation into interaction between bile salts and insulin in alkaline aqueous solution. J. Colloid Interface Sci. 2009,337(2):322-331.
16. Hao AJ, Deng YJ*, Li TF, Suo XB, Cao YH, Hao YL, Zhang Y. Degradation kinetics of fluorouracil-acetic-acid-dextran conjugate in aqueous solution. Drug Dev. Ind. Pharm. 2006,32(6):757-63.
17. Hao YL, Deng YJ*, Chen Y, Wang KZ, Hao AJ, Zhang Y. In-vitro cytotoxicity, in-vivo biodistribution and antitumor effect of PEGylated liposomal topotecan. J. Pharm. Pharmacol. 2005,57: 1279-1287.
京公网安备 11010802027423号